spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  Toric 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 28 Jul 2026
BrainStorm Appoints Former FDA Associate Commissioner Peter J. Pitts as Executive Chairman
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 27 Jul 2026
IceCure Medical Kicks Off its Post-Marketing "ChoICE" Study for the Low-Risk Breast Cancer Treatment at First U.S Clinical Site
Devices Oncology
 HSMN NewsFeed - 16 Jul 2026
Lilly to Acquire AtaiBeckley to Advance Therapies for Treatment-Resistant Depression and Other Mental Health Conditions
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 6 Jul 2026
IceCure Highlights Expanding Commercial Adoption of ProSense(TM) Cryoablation in Brazil Following FDA Clearance for Breast Cancer
Devices Oncology
 HSMN NewsFeed - 29 Jun 2026
Theravance Biopharma Enters into Definite Agreement to be Acquired by Zymeworks for $17.00 Per Share in Cash Plus a Contingent Value Right
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 13 May 2026
Whitehawk Therapeutics Announces $87.5M Private Placement Equity Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 12 May 2026
Bayesian Health Receives First-Ever FDA Clearance for Continuous AI Sepsis Monitoring
Devices Monitoring FDA
 HSMN NewsFeed - 11 May 2026
Partner Therapeutics Announces FDA Approval of BIZENGRI(R) (Zenocutuzumab-zbco) for NRG1 Fusion-Positive Cholangiocarcinoma Following Receipt of FDA Commissioner's National Priority Voucher
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 14 Apr 2026
Avanos Medical, Inc. Agrees To Be Acquired by American Industrial Partners for Approximately $1.272 Billion
Devices Mergers & Acquisitions
 HSMN NewsFeed - 7 Apr 2026
Tetrous(R) Announces Completion of First Cases with EnFix ACL(TM) for ACL Reconstruction
Devices Orthopaedic
 HSMN NewsFeed - 6 Apr 2026
Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 31 Mar 2026
Lilly to Acquire Centessa Pharmaceuticals to Advance Treatments for Sleep-Wake Disorders
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Mar 2026
IceCure Reports Positive 5-Year Top-Line Results from ICESECRET Kidney Cancer Cryoablation Study: 89.4% and 83.9% Recurrence-Free Rates
Devices Interventional Oncology
 HSMN NewsFeed - 9 Mar 2026
Baird Medical Accelerates U.S. Expansion in Interventional Thyroidology at NASIT 2026
Devices Interventional
 HSMN NewsFeed - 6 Mar 2026
U.S. FDA Approves TECVAYLI(R) in Combination with DARZALEX FASPRO(R) for Relapsed/Refractory Multiple Myeloma
Biopharmaceuticals Oncology Drug Delivery FDA
 HSMN NewsFeed - 3 Mar 2026
Xsensio SA Raises $7M Oversubscribed Series A, Accelerates Clinical Deployment of Continuous Biosensing
Devices Monitoring Venture Capital
 HSMN NewsFeed - 26 Feb 2026
Brainstorm Cell Therapeutics Secures Second $1 Million Strategic Placement; Total $2 Million Raised In February
Regenerative Medicine Neurology Venture Capital
 HSMN NewsFeed - 25 Feb 2026
Vanda Pharmaceuticals Announces FDA Acceptance of Biologics License Application Filing for Imsidolimab for the Treatment of Generalized Pustular Psoriasis
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Feb 2026
Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing at Premium to Market
Regenerative Medicine Neurology Venture Capital
 HSMN NewsFeed - 16 Feb 2026
P-Cure Announces First-Ever Prospective Clinical Results of Gantry-Less Upright Proton Therapy for Lung Cancer Re-Irradiation
Devices Oncology
 HSMN NewsFeed - 11 Feb 2026
Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease Assessment in Primary Care
Diagnostics Neurology Product Launch
 HSMN NewsFeed - 28 Jan 2026
REGENXBIO Announces Regulatory Update on Ultra Rare MPS Programs
Regenerative Medicine FDA
 HSMN NewsFeed - 20 Jan 2026
Think Bioscience Raises $55M in Oversubscribed Series A
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Jan 2026
Haemonetics Acquires Vivasure Medical Limited
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 5 Jan 2026
ScinoPharm Secures U.S. FDA Approval for Glatiramer Acetate Injection for the Treatment of Multiple Sclerosis
Biopharmaceuticals Generics Neurology FDA
 HSMN NewsFeed - 29 Dec 2025
FDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Dec 2025
Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 Dec 2025
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 3 Dec 2025
Shoulder Innovations Announces Strategic Partnership with INS to Introduce a Robotic Platform for Shoulder Arthroplasty
Devices Orthopaedic
 HSMN NewsFeed - 28 Nov 2025
Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Nov 2025
Hollister Incorporated Drives Major Policy Change to Expand Access to Closed System Intermittent Catheters for People with Spinal Cord Injuries
Devices Urology Regulatory
 HSMN NewsFeed - 10 Nov 2025
Par Health Completes Spin-Off from Mallinckrodt, Creating an Independent Leader in Generic Pharmaceuticals and Sterile Injectables
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 5 Nov 2025
Volta Medical Brings Volta AF-Xplorer(TM) II to the U.S., Ushering in a New Era of AI in Ablation for Complex Atrial Fibrillation
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 27 Oct 2025
Hemab Therapeutics Announces $157 Million Series C Financing to Advance Next-Generation Treatments for Underserved Bleeding Disorders
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 21 Oct 2025
Onkos Surgical(R) Receives FDA 510(k) Clearance for ELEOS(TM) Proximal Tibia with NanoCept(R) Antibacterial Technology
Devices Orthopaedic FDA
 HSMN NewsFeed - 21 Oct 2025
PleoPharma, Inc. Closes $36 Million Series B Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Sep 2025
Accuray Launches All-in-One Radiotherapy Solution With Advanced Capabilities Designed to Set a New Standard in Cancer Care
Devices Oncology Product Launch
 HSMN NewsFeed - 27 Aug 2025
Leal Therapeutics Announces $30 Million Series A to Progress First-In-Class Neuro-Metabolic Therapies for Neurodegenerative and Neuropsychiatric Disorders with High-Unmet Need
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 20 Aug 2025
Anne White to Retire as Executive Vice President and President, Lilly Neuroscience
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 20 Aug 2025
CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR
Devices FDA
 HSMN NewsFeed - 15 Aug 2025
Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Aug 2025
Superluminal Medicines Announces Collaboration with Eli Lilly and Company to Advance Small Molecule Therapeutics for Cardiometabolic Diseases and Obesity
Biopharmaceuticals
 HSMN NewsFeed - 6 Aug 2025
Mallinckrodt Names Christiana Stamoulis as President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jul 2025
Leo Cancer Care Receives FDA 510(k) Clearance for Marie(R) - A Revolutionary Upright Radiotherapy Platform
Devices Oncology FDA
 HSMN NewsFeed - 14 Jul 2025
Zimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous Solutions
Devices Orthopaedic Mergers & Acquisitions
 HSMN NewsFeed - 8 Jul 2025
Soligenix Corporate Update Letter - Key Highlights and Upcoming Milestones
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Jun 2025
Sephience(TM) (sepiapterin) Granted Marketing Authorization by the European Commission for the Treatment of Children and Adults Living with Phenylketonuria (PKU)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 20 Jun 2025
Lomond Therapeutics Announces U.S. FDA Clearance of IND Application for Lonitoclax, a Selective BCL2 Inhibitor with Limited Immune Suppression and Improved Safety Compared to Venetoclax and Venetoclax- Like Molecules
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Jun 2025
Penumbra Introduces the Ruby(R) XL System - the Longest, Largest, and Softest Coil on the Market for Vascular Embolization
Devices Interventional FDA Product Launch
 HSMN NewsFeed - 2 Jun 2025
Sanofi to Acquire Blueprint Medicines, Expanding Portfolio in Rare Immunological Disease and Adding Early-stage Pipeline in Immunology
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 May 2025
BrainStorm Secures Key Manufacturing Partnership with Minaris for Upcoming NurOwn(R) Phase 3b ALS Clinical Trials
Regenerative Medicine Neurology
 HSMN NewsFeed - 19 May 2025
BrainStorm Receives FDA Clearance to Initiate Phase 3b Trial of NurOwn(R) for ALS
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 16 May 2025
BioMarin Strengthens Enzyme Therapy Business with Acquisition of Inozyme Pharma
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 Apr 2025
Regulus Therapeutics Enters into Agreement to be Acquired by Novartis AG
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 28 Apr 2025
IceCure Exhibits ProSense(R) & Sponsors Breast Cryoablation Courses at the Society of Breast Imaging Symposium
Devices Oncology
 HSMN NewsFeed - 14 Apr 2025
CytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North America
Devices Personnel
 HSMN NewsFeed - 10 Apr 2025
BrainStorm Cell Therapeutics Submits IND Amendment to FDA, Paving the Way for Phase 3b Trial of NurOwn(R) in ALS
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 4 Apr 2025
Neurocrine Biosciences Appoints Dr. Sanjay Keswani as Chief Medical Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 31 Mar 2025
Lomond Therapeutics Completes Second and Third Closings and adds Two New Investors
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 13 Mar 2025
Mallinckrodt and Endo to Combine to Create a Global, Scaled, Diversified Pharmaceuticals Leader
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 5 Mar 2025
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 24 Feb 2025
IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense(TM) Cryoablation System in Israel
Devices Oncology Regulatory
 HSMN NewsFeed - 10 Feb 2025
Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Moderate-to-Severe Atopic Dermatitis
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 4 Feb 2025
MedRhythms Hires Joel Behnke as Chief Commercial Officer; Announces New Publications in Support of InTandem(R)
Devices Neurology Personnel
 HSMN NewsFeed - 3 Feb 2025
CHMP Issues Positive Opinion for Subcutaneous RYBREVANT(R)(amivantamab) Co-Formulated with ENHANZE(R) for the Treatment of Patients with Advanced EGFR-Mutated Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 30 Jan 2025
Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 17 Jan 2025
FDA Approves LUMAKRAS(R) (Sotorasib) in Combination with Vectibix(R) (Panitumumab) for Chemorefractory KRAS G12C-Mutated Metastatic Colorectal Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 16 Jan 2025
UCB Announces U.S. Availability of 320 mg/2 mL Single-Injection Administration Option for BIMZELX(R) (bimekizumab-bkzx)
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 7 Jan 2025
Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment
Devices Interventional
 HSMN NewsFeed - 31 Dec 2024
Kazia Therapeutics Provides Update on Paxalisib Regulatory Pathway Following Type C Meeting with FDA
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 30 Dec 2024
Halozyme Announces FDA Approval of Bristol Myers Squibb's Opdivo Qvantig(TM) with ENHANZE(R) for Subcutaneous Use in Most Previously Approved Adult Solid Tumor Opdivo(R) (nivolumab) Indications
Biopharmaceuticals Drug Delivery Oncology FDA
 HSMN NewsFeed - 26 Dec 2024
Coeptis Therapeutics Makes Bold Strides in Innovation with the Acquisition of NexGenAI Affiliates Network Platform and Launch of Coeptis Technologies
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 20 Dec 2024
Neurocrine Biosciences Announces Commercial Availability of CRENESSITY(TM) (crinecerfont) for Children and Adults With Classic Congenital Adrenal Hyperplasia
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 19 Dec 2024
Astellas and Sangamo Therapeutics Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 18 Dec 2024
New Data Indicates the CyberKnife(R) System Can Provide a Safe and Effective Treatment Option to Control Brainstem Metastases, an Extremely Challenging Location to Treat
Devices Oncology Neurosurgery
 HSMN NewsFeed - 12 Dec 2024
U.S. FDA Expands Indication for Impella Heart Pumps to Treat Pediatric Patients
Devices Cardiology FDA
 HSMN NewsFeed - 2 Dec 2024
Mallinckrodt Completes Divestiture of Therakos(R) Business
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 27 Nov 2024
PTC Therapeutics Enters into Agreement to Sell Priority Review Voucher for $150 Million
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Nov 2024
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Nov 2024
SOPHiA GENETICS Launches MSK-IMPACT(R) powered with SOPHiA DDM(TM) at AMP 2024
Diagnostics Product Launch
 HSMN NewsFeed - 8 Nov 2024
FDA Advisory Panel Votes in Favor of IceCure's ProSense(R) Cryoablation Benefit-Risk Profile in Early-Stage Low Risk Breast Cancer
Devices Oncology FDA
 HSMN NewsFeed - 6 Nov 2024
I-Mab Appoints Sean Fu, PhD, MBA, as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 1 Nov 2024
CARsgen(R) U.S. Clinical Holds Lifted by FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 31 Oct 2024
Lipocine Announces Distribution and License Agreement with SPC Korea to Commercialize TLANDO(R) in South Korea
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 21 Oct 2024
Kyverna Therapeutics Appoints Mert Aktar to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Oct 2024
CHMP Maintains Negative Opinion on Translarna(TM) Reexamination
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 3 Oct 2024
Avidity Biosciences Announces FDA Removed Partial Clinical Hold on Delpacibart Etedesiran (del-desiran/AOC 1001)
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Oct 2024
Kedrion and Biotest complete long-term Exclusive Distribution Agreement for Yimmugo(R) in the US
Biopharmaceuticals Distribution
 HSMN NewsFeed - 26 Sep 2024
FDA Grants Fast Track Designation to PTC518 Huntington's Disease Program
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 23 Sep 2024
UCB Announces U.S. FDA Approvals for BIMZELX(R) (bimekizumab-bkzx) for the Treatment of Psoriatic Arthritis, Non-Radiographic Axial Spondyloarthritis, and Ankylosing Spondylitis
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Sep 2024
FDA Declines to Approve Vanda's Marketing Application for Tradipitant in Gastroparesis
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Sep 2024
Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash(TM) 2.0 and Lightning Bolt(TM) 7 - in Europe
Devices Interventional Regulatory
 HSMN NewsFeed - 27 Aug 2024
Endo Announces CEO Transition
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Aug 2024
Quest Diagnostics Completes Acquisition of LifeLabs, Enhancing Access to Diagnostic Innovation
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 16 Aug 2024
Lilly Completes Acquisition of Morphic to Improve Outcomes and Expand Options for People Living with Inflammatory Bowel Disease
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Aug 2024
Haemonetics Announces Full Market Release for VASCADE MVP(R) XL Vascular Closure System
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 14 Aug 2024
IceCure's ProSense(R) Destroyed 100% of Breast Cancer Tumors in Independent Study of Patients Who Chose Cryoablation Instead of Surgery
Devices Oncology
 HSMN NewsFeed - 5 Aug 2024
Mallinckrodt Reaches Agreement to Sell Therakos(R) Business to CVC for $925 Million
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 8 Jul 2024
Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 26 Jun 2024
BrainStorm Cell Therapeutics Reaches Alignment with FDA on CMC Aspects of Phase 3b NurOwn(R) Clinical Trial
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 25 Jun 2024
Halozyme Announces Roche's OCREVUS(R) SC with ENHANZE(R) Receives European Commission Approval for Relapsing and Primary Progressive Multiple Sclerosis
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 24 Jun 2024
Harmony Biosciences Receives U.S. Food And Drug Administration Approval For Wakix(R) (Pitolisant) In Pediatric Patients With Narcolepsy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 20 Jun 2024
BrainStorm Cell Therapeutics Announces Appointment of Haro Hartounian Ph.D. as Chief Operating Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 12 Jun 2024
REGENXBIO Announces Leadership Transition
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jun 2024
I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Jun 2024
Lilly announces departure of Anat Ashkenazi, chief financial officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jun 2024
BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader
Devices Monitoring Acquisitions
 HSMN NewsFeed - 21 May 2024
Biocon Biologics Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili(TM). Enters U.S. Ophthalmology Market
Biopharmaceuticals Generics Ophthalmology FDA
 HSMN NewsFeed - 14 May 2024
Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Apr 2024
Q32 Bio Appoints Lee Kalowski as President & Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Apr 2024
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 26 Mar 2024
Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS(R)
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 25 Mar 2024
Poseida Therapeutics Appoints Syed Rizvi, M.D., as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Mar 2024
Astellas Receives Positive CHMP Opinion for XTANDI(TM) in Additional Recurrent Early Prostate Cancer Treatment Setting
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 21 Mar 2024
Renibus Announces Leadership Transition
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Mar 2024
Fusion Pharmaceuticals to be Acquired by AstraZeneca, Accelerating Development of Next-Generation Radioconjugates to Treat Cancer
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 11 Mar 2024
FDA Grants Orphan Drug and Pediatric Exclusivities for CRESEMBA(R) (isavuconazonium sulfate) for Invasive Aspergillosis and Invasive Mucormycosis in Children
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Mar 2024
ADI Announces U.S. FDA 510(k) Clearance and the Commercial Launch of Sensinel by Analog Devices(TM) Cardiopulmonary Management (CPM) System
Devices Cardiology Monitoring FDA
 HSMN NewsFeed - 5 Mar 2024
Haemonetics Announces Definitive Agreement to Acquire Attune Medical
Devices Mergers & Acquisitions
 HSMN NewsFeed - 28 Feb 2024
Baird Medical Expands Presence in the United States
Devices Oncology Personnel
 HSMN NewsFeed - 26 Feb 2024
Study Using IceCure's ProSense(R) Treatment Results in 100% Tumor Reduction in Early-Stage Breast Cancer
Devices Oncology
 HSMN NewsFeed - 23 Feb 2024
BrainStorm Cell Therapeutics Submits Special Protocol Assessment (SPA) Request to FDA for Phase 3b Trial of NurOwn(R) in ALS
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 22 Feb 2024
Zimmer Biomet Receives FDA Clearance for ROSA(R) Shoulder System - the World's First Robotic Assistant for Shoulder Replacement Surgery
Devices Orthopaedic FDA
 HSMN NewsFeed - 20 Feb 2024
Avidity Biosciences Receives FDA Rare Pediatric Disease Designation for AOC 1044 for Treatment of Duchenne Muscular Dystrophy in People with Mutations Amenable to Exon 44 Skipping
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Feb 2024
Fusion Pharmaceuticals Enters into Exclusive Worldwide License Agreement with Heidelberg University and Euratom for Actinium-Based PSMA Targeted Radiotherapy
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 9 Feb 2024
YS Biopharma Announces US$40 Million Private Placement Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Feb 2024
Zynex Receives FDA Clearance for its Next Generation NMES Device
Devices FDA
 HSMN NewsFeed - 5 Feb 2024
Spyre Therapeutics Appoints Accomplished Biopharma and IBD Leader Mark C. McKenna, Former Chairman, President, and CEO of Prometheus Biosciences, to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Feb 2024
Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Jan 2024
IceCure Medical's Breast Cryoablation Gains Prominence in the U.S., as Society of Interventional Oncology Annual Meeting Features its First Breast Cryoablation Master Class
Devices Oncology
 HSMN NewsFeed - 25 Jan 2024
Providence Swedish Radiosurgery Center in Seattle Invests in Second Accuray CyberKnife(R) System, a Robotic Delivery Device That Makes Extremely Precise Radiation Treatments Possible in 1-5 Sessions
Devices Oncology
 HSMN NewsFeed - 27 Dec 2023
Lilly Completes Acquisition of POINT Biopharma
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Dec 2023
Amgen Provides Regulatory Update on Status of Lumakras(R) (Sotorasib)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 25 Oct 2023
Independent Scientific Paper by Doctors Using IceCure's ProSense(R) Published in Journal of Breast Imaging Presents Advantages of Cryoablation Breast Conserving Over Surgery in Early Breast Cancer Patients
Devices Oncology
 HSMN NewsFeed - 24 Oct 2023
BrainStorm Cell Therapeutics Announces Strategic Realignment Prioritizing NurOwn(R) for the Treatment of ALS
Regenerative Medicine Neurology
 HSMN NewsFeed - 18 Oct 2023
BrainStorm Cell Therapeutics to Meet with US FDA to Discuss Development Plan for NurOwn as a Treatment of ALS
Regenerative Medicine Neurology
 HSMN NewsFeed - 6 Oct 2023
Amgen Completes Acquisition of Horizon Therapeutics plc
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Sep 2023
Gensco(R) Pharma Announces RizaFilm(R) Commercialization Update in the United States
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 20 Sep 2023
IceCure Medical Receives FDA Response to De Novo Classification Request for Breast Cancer
Devices FDA
 HSMN NewsFeed - 12 Sep 2023
Protalix BioTherapeutics Appoints Eliot Richard Forster, Ph.D. as Chairman of its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Sep 2023
enGene Appoints Richard Bryce, MBChB, MRCGP, MFPM, as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Sep 2023
Aeglea BioTherapeutics Expands Executive Leadership Team with Appointment of Industry Veterans Scott Burrows and Heidy Abreu King-Jones
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Aug 2023
Haemonetics Announces European Expansion for VASCADE(R) Vascular Closure System
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Aug 2023
Zimmer Biomet Announces Leadership Transition
Devices Orthopaedic Personnel
 HSMN NewsFeed - 10 Aug 2023
Baird Medical Submits Disposable Microwave Ablation Needle and MWA System Application to U.S. FDA for Treatment of Soft Tissue Microwave Ablation
Devices FDA
 HSMN NewsFeed - 17 Jul 2023
ViewRay(R) Files Voluntary Chapter 11 Petitions
Devices Oncology
 HSMN NewsFeed - 13 Jul 2023
Elevation Oncology Appoints Joseph Ferra as Chief Executive Officer and Promotes Tammy Furlong to Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Jul 2023
BrainStorm Cell Therapeutics Appoints Bob Dagher, M.D., as Executive Vice President and Chief Development Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 29 Jun 2023
Lilly to Acquire Sigilon Therapeutics
Biopharmaceuticals Endocrinology Mergers & Acquisitions
 HSMN NewsFeed - 23 Jun 2023
Regulus Therapeutics Announces Appointment of Preston S. Klassen, M.D. to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jun 2023
Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 14 Jun 2023
Carisma Therapeutics Appoints Eric Siegel as General Counsel and Corporate Secretary and Terry Shields as Senior Vice President of Human Resources
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Jun 2023
VA Oklahoma City Healthcare System Chooses ViewRay's MRIdian(R) MRI-Guided Radiation Therapy System
Devices Oncology
 HSMN NewsFeed - 9 Jun 2023
Astellas Submits New Drug Application for Zolbetuximab in Japan
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 8 Jun 2023
Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430
Biopharmaceuticals Regenerative Medicine Licensing
 HSMN NewsFeed - 1 Jun 2023
Penumbra Expands Computer-Aided Thrombectomy Offerings with Lightning Bolt 7 Technology Designed to Rapidly Remove Blood Clots with Modulated Aspiration
Devices Interventional Product Launch FDA
 HSMN NewsFeed - 17 May 2023
PTC Therapeutics Announces APHENITY Trial Achieved Primary Endpoint with Sepiapterin in PKU Patients
Biopharmaceuticals
 HSMN NewsFeed - 4 May 2023
Soligenix Announces Positive Clinical Results from Compatibility Study of HyBryte(TM) in the Treatment of Cutaneous T-Cell Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 Apr 2023
Lilly to Divest BAQSIMI to Amphastar
Biopharmaceuticals Endocrinology Mergers & Acquisitions
 HSMN NewsFeed - 14 Apr 2023
Soligenix Provides Regulatory Update on HyBryte(TM)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 27 Mar 2023
BrainStorm Cell Therapeutics Announces FDA Advisory Committee Meeting to Review Biologics License Application for NurOwn(R) for the Treatment of ALS
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 20 Mar 2023
NuVasive Specialized Orthopedics Expands Indications of Precice Limb Lengthening System to Treat Pediatric Patients
Devices Orthopaedic FDA
 HSMN NewsFeed - 13 Mar 2023
NuVasive Celebrates 20-Year Milestone of the XLIF Procedure
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 3 Mar 2023
Aadi Bioscience Announces Leadership Transition
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Mar 2023
Siteman Cancer Center at Washington University Treats 2,000th Patient with MRIdian(R) MRI-Guided Radiation Therapy
Devices Oncology
 HSMN NewsFeed - 17 Feb 2023
Medtronic Receives CE Mark for Extravascular Defibrillator System That Treats Abnormal Heart Rhythms
Devices Cardiology Regulatory
 HSMN NewsFeed - 15 Feb 2023
Sera Prognostics Announces Positive Top-line Data from AVERT PRETERM TRIAL
Diagnostics
 HSMN NewsFeed - 14 Feb 2023
Soligenix Receives Refusal to File Letter from U.S. FDA for HyBryte(TM) New Drug Application in the Treatment of Cutaneous T-Cell Lymphoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 2 Feb 2023
Tezspire(R) Approved for Self-Administration in the U.S. with a New Pre-Filled Pen
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 23 Jan 2023
Cadrenal Therapeutics (Nasdaq: CVKD) Granted FDA Fast Track Designation for Tecarfarin for Prevention of Systemic Thromboembolism of Cardiac Origin in Patients with End-Stage Renal Disease and Atrial Fibrillation
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Jan 2023
Astellas Announces Hold Lifted by FDA on FORTIS Clinical Trial of AT845 Investigational Treatment for Adult Patients with Late-Onset Pompe Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Jan 2023
NeuroBo Pharmaceuticals Appoints Joseph Hooker as Interim Chief Executive Officer and President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jan 2023
Mallinckrodt Announces Appointment of Dr. Peter Richardson, MRCP, as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jan 2023
ZyVersa Therapeutics Appoints Three New Board Members
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jan 2023
Zimmer Biomet to Acquire Embody, Inc.
Devices Orthopaedic Mergers & Acquisitions
 HSMN NewsFeed - 2 Jan 2023
Blacksmith Medicines Announces Merger with Forge Therapeutics to Create Leading Company Developing Medicines Targeting Metalloenzymes
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Dec 2022
FDA Grants Appeal for Ardelyx's XPHOZAH(R) (tenapanor)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 27 Dec 2022
BrainStorm Cell Therapeutics Announces Type A Meeting with FDA Granted for NurOwn(R)
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 8 Dec 2022
Edwards Lifesciences Announces CEO Succession Plan
Devices Personnel
 HSMN NewsFeed - 30 Nov 2022
Chemomab Announces Appointment of Mitchell L. Jones, MD, PhD as Vice President of Corporate Development & Strategy
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Nov 2022
Regulus Therapeutics Announces Appointments of Industry Veterans, Drs. Rekha Garg and Claire Padgett, to Lead Clinical Development, Regulatory and Clinical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Nov 2022
U.S. Food and Drug Administration Approves CSL's Hemgenix(R) eEtranacogene dezaparvovec-drlb), the First Gene Therapy for Hemophilia B
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Nov 2022
Synaptogenix Announces $15 Million Private Placement with Existing Investors
Biopharmaceuticals Regenerative Medicine Venture Capital
 HSMN NewsFeed - 17 Nov 2022
Upstaza(TM) Gene Therapy Granted Marketing Authorization for AADC deficiency by UK's MHRA
Regenerative Medicine Neurology Regulatory
 HSMN NewsFeed - 16 Nov 2022
Oscar Lambret Center in France Installs Second Accuray Radixact(R) System, the Hospital's Fifth Accuray Radiation Therapy Delivery System
Devices Oncology
 HSMN NewsFeed - 10 Nov 2022
BrainStorm Cell Therapeutics Receives Refusal to File Letter from FDA for its New Biologics License Application for NurOwn for the treatment of ALS
Biopharmaceuticals Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 8 Nov 2022
Sensorium Therapeutics Closes $30 Million Series A to Transform Mental Health Treatment with Nature-Inspired Psychoactive Medicines
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Nov 2022
US Biologic(R) to Present Development of a Chewable Flu Vaccine: Offers New Tool to Increase Vaccine Equity, Avoid Needles, and Reduce Pandemics
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 3 Nov 2022
Grifols Receives FDA Clearance for Alphaid(TM) At Home, the First Free Service for U.S. Consumers to Determine Their Risk for Alpha-1
Diagnostics FDA
 HSMN NewsFeed - 2 Nov 2022
'Enhanced Lung Rest' with CytoSorb and ECMO Achieves High Survival in 100 Critically Ill COVID-19 Patients with Refractory Lung Failure from Five Major U.S. Hospitals
Devices
 HSMN NewsFeed - 26 Oct 2022
New Reimbursement Approved by the Japanese Ministry of Health, Labor and Welfare for the Accuray CyberKnife(R) System to Treat Trigeminal Neuralgia, a Condition Often Causing Severe Facial Pain
Devices Reimbursement
 HSMN NewsFeed - 24 Oct 2022
Medtronic Announces Intention to Separate its Combined Patient Monitoring and Respiratory Interventions Businesses
Devices Monitoring Mergers & Acquisitions
 HSMN NewsFeed - 24 Oct 2022
ViewRay Announces Primary Endpoint Outcome from First Prospective, Multi-Institutional Study to Deliver Ablative Doses of Radiation to Pancreatic Cancer Patients
Devices Oncology
 HSMN NewsFeed - 30 Sep 2022
Accuray Announces First CyberKnife(R) Systems in Africa, Providing a New Option and Hope for Potentially Life-Saving Radiation Treatments for More Cancer Patients
Devices Oncology
 HSMN NewsFeed - 28 Sep 2022
Harrow Announces U.S. FDA Approval of IHEEZO(TM) (Chloroprocaine Hydrochloride Ophthalmic Gel) 3% for Ocular Surface Anesthesia
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 20 Sep 2022
MD Anderson Cancer Center Selects ViewRay to Expand MR-Guided Radiation Therapy Program
Devices Oncology
 HSMN NewsFeed - 19 Sep 2022
Mallinckrodt Announces Appointment of Lisa French as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Sep 2022
BrainStorm Cell Therapeutics Announces Peer Reviewed Publication of Results from the NurOwn(R) Phase 2 Progressive MS Trial in Multiple Sclerosis Journal
Regenerative Medicine Neurology
 HSMN NewsFeed - 14 Sep 2022
Dr. Seth Blacksburg Joins Accuray as VP, Chief Medical Officer Americas Region
Devices Oncology Personnel
 HSMN NewsFeed - 12 Sep 2022
Haemonetics Earns CE Mark for VASCADE(R) Vascular Closure Product Portfolio
Devices Interventional Regulatory
 HSMN NewsFeed - 8 Sep 2022
GenesisCare Purchases Two Additional ViewRay MRIdian MRI-guided Radiotherapy Systems for Guildford and Birmingham Projects, Doubling United Kingdom Footprint to Four Systems
Devices Oncology
 HSMN NewsFeed - 7 Sep 2022
ViewRay Announces China NMPA Approval of its MRIdian(R) MRI-Guided Radiation Therapy for Cancer Patients
Devices Oncology Regulatory
 HSMN NewsFeed - 1 Sep 2022
Nevro Announces Multiple Positive Coverage Updates for the Treatment of Painful Diabetic Neuropathy
Devices Reimbursement
 HSMN NewsFeed - 23 Aug 2022
VA Houston Healthcare System Selects ViewRay to Expand Advanced Radiation Therapy Services
Devices Oncology
 HSMN NewsFeed - 23 Aug 2022
IRRAS Announces First Patient Treatments at Mount Sinai Health System in New York as Part of the DIVE Study
Devices Neurosurgery Monitoring
 HSMN NewsFeed - 18 Aug 2022
U.S. FDA Accepts Astellas' New Drug Application for Fezolinetant
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Aug 2022
Chemomab Adds Highly Experienced Executives Further Strengthening Its R&D and Clinical Capabilities
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Aug 2022
Kodiak Sciences Reports Positive Topline Results from BEACON Phase 3 Study of Tarcocimab Tedromer (KSI-301) in Patients with Retinal Vein Occlusion
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 1 Aug 2022
Armata Pharmaceuticals Announces Clearance of IND for Prosthetic Joint Infections
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Jul 2022
Clinical Study Validates NuVasive Porous Interbody Implant and Synthetic Bone Graft Substitute as Cost-effective Solution for Lateral Lumbar Interbody Fusions
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 19 Jul 2022
Gracell Biotechnologies Appoints Veteran BioPharma Executive Dr. Samuel Zhang as Chief Business Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Jul 2022
Saitama Medical University International Medical Center Selects MRIdian(R) MRI-Guided Radiation Therapy System
Devices Oncology
 HSMN NewsFeed - 13 Jul 2022
Mauna Kea Technologies Announces Publication of a Meta-Analysis Demonstrating Cellvizio’s Significant Role in Detection of Esophageal Dysplasia and Cancer
Devices Diagnostics Oncology
 HSMN NewsFeed - 12 Jul 2022
Accuray CyberKnife(R) System Real World Data and Clinical Studies Show Benefits in Treatment of Neurological Indications
Devices Oncology Neurosurgery
 HSMN NewsFeed - 11 Jul 2022
Anthos Therapeutics Announces that Abelacimab has Received FDA Fast Track Designation for the Treatment of Thrombosis Associated with Cancer
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Jul 2022
Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Maria Törnsén
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jul 2022
Newly Released Clinical Data Demonstrates Substantial Improvement in Overall Health-Related Quality of Life in Patients with Painful Diabetic Neuropathy Treated with Nevro HFX Spinal Cord Stimulation Therapy
Devices Neurology
 HSMN NewsFeed - 5 Jul 2022
Lyra Therapeutics Announces Appointment of Richard Nieman, MD, as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jun 2022
Advanced NanoTherapies Announces Closing of Oversubscribed $7.2 Million Series A Financing
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 23 Jun 2022
Tryp Therapeutics Appoints New Chief Operating Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 21 Jun 2022
Chemomab Therapeutics Appoints Jill M. Quigley, JD, to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jun 2022
VA Ann Arbor Healthcare System Selects ViewRay to Expand Advanced Radiation Therapy Services
Devices Oncology
 HSMN NewsFeed - 7 Jun 2022
Shin-Matsudo Central General Hospital Select's ViewRay's MRIdian(R) MRI-Guided Radiation Therapy System to Expand Access to Precision Radiation Therapy
Devices Oncology
 HSMN NewsFeed - 2 Jun 2022
Accuray and Limbus AI Inc. Partner to Leverage Limbus' Innovative AI-driven Technology to Enhance Accuray Adaptive Radiotherapy Solutions
Devices Oncology
 HSMN NewsFeed - 2 Jun 2022
Henry Ford Health Becomes the First Center to Treat Patients with ViewRay's MRIdian A3i System
Devices Oncology
 HSMN NewsFeed - 1 Jun 2022
CytoSorbents Partners with Nikkiso to Distribute the PureADJUST Hemoperfusion Blood Pump and Supplies in 14 Countries
Devices Distribution
 HSMN NewsFeed - 31 May 2022
Embody, Inc. Announces 510(k) Clearances for TAPESTRY(R) RC for Rotator Cuff Repair
Devices Regenerative Medicine Orthopaedic FDA
 HSMN NewsFeed - 31 May 2022
Sapience Therapeutics Announces $41 Million Series B Financing to Advance Pipeline of Peptide Therapeutics Targeting Protein-Protein Interactions
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 31 May 2022
Abbott's FreeStyle Libre(R) 3 Receives U.S. FDA Clearance - Features World's Smallest, Thinnest and Most Accurate 14-Day Glucose Sensor
Devices Endocrinology Monitoring FDA
 HSMN NewsFeed - 30 May 2022
Tetra Bio-Pharma Appoints Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 May 2022
Tryp Therapeutics Strengthens Board of Directors with Appointment of Chris Ntoumenopoulos as Independent Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 May 2022
Insmed Names Drayton Wise Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 May 2022
PTC Therapeutics Receives Positive CHMP Opinion for Upstaza(TM) for the Treatment of AADC Deficiency
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 18 May 2022
Theseus Pharmaceuticals Appoints Don Hayden to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 17 May 2022
Accuray Appoints Sandeep Chalke as SVP, Chief Commercial Officer
Devices Oncology Personnel
 HSMN NewsFeed - 16 May 2022
RadNet Artificial Intelligence Subsidiaries, DeepHealth and Quantib, Obtain FDA Clearance for Mammography and Prostate AI Tools
Devices Radiology FDA
 HSMN NewsFeed - 13 May 2022
Medtronic completes acquisition of Intersect ENT
Devices Mergers & Acquisitions
 HSMN NewsFeed - 6 May 2022
NeuroBo Pharmaceuticals, Inc. Expands Management Team with the Appointment of Matthew Bardin, PharmD, BCPS as Senior Vice President Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 May 2022
UCI Health Adopts ViewRay(R) MRIdian(R) MRI-Guided Radiation Therapy System
Devices Oncology
 HSMN NewsFeed - 2 May 2022
Supernus Announces FDA Approval of Qelbree(R) for the Treatment of ADHD in Adults
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 2 May 2022
CytoSorbents Awarded Preferred Supplier Agreement with Asklepios, One of the Largest Private Hospital Operators in Germany
Devices Group Purchasing
 HSMN NewsFeed - 26 Apr 2022
Halozyme Commences Tender Offer for All Outstanding Shares of Common Stock of Antares Pharma
Biopharmaceuticals Drug Delivery Mergers & Acquisitions
 HSMN NewsFeed - 26 Apr 2022
Lantern Pharma's Board of Directors Names Maria Maccecchini, Ph.D. as a Director Nominee to Lantern's Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 21 Apr 2022
NuVasive Simplify Cervical Disc Two-level Data Published in Journal of Neurosurgery: Spine
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 13 Apr 2022
Lyra Therapeutics Announces Closing of $100.5 Million Private Placement
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Apr 2022
Halozyme to Acquire Antares Pharma to Create a Specialty Product and Drug Delivery Leader
Biopharmaceuticals Drug Delivery Mergers & Acquisitions
 HSMN NewsFeed - 7 Apr 2022
Jazz Pharmaceuticals and Werewolf Therapeutics Announce Exclusive Global License and Collaboration Agreement to Develop WTX-613, a Differentiated, Conditionally-Activated IFNα INDUKINE(TM) Molecule
Biopharmaceuticals Licensing
 HSMN NewsFeed - 4 Apr 2022
Ardelyx Announces US Launch of IBSRELA(R), a New First-in-Class Treatment for IBS-C in Adults
Biopharmaceuticals Gastroenterology Product Launch
 HSMN NewsFeed - 31 Mar 2022
Sapience Therapeutics Expands Executive Team with Appointment of Gina Capiaux, Ph.D. as Vice President, Regulatory Affairs
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 31 Mar 2022
10-Year Data Shows Accuray CyberKnife(R) System Provides Long-Lasting Relief of the Excruciating Pain Caused by Trigeminal Neuralgia
Devices Oncology
 HSMN NewsFeed - 30 Mar 2022
Omega Therapeutics Strengthens Team With Key Management Appointments To Support Its Growth
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Mar 2022
Stem cell biotech Neuroplast enrolls first patient in Phase II clinical trial of transformative Neuro-Cells(R) treatment for Traumatic Spinal Cord Injury
Regenerative Medicine Neurology
 HSMN NewsFeed - 28 Mar 2022
Jazz Pharmaceuticals Announces Agreement to Divest Sunosi(R) (solriamfetol) to Axsome Therapeutics
Biopharmaceuticals Neurology Acquisitions
 HSMN NewsFeed - 21 Mar 2022
NeuroSense Therapeutics Receives FDA Clearance of IND for PrimeC for the Treatment of ALS
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 18 Mar 2022
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Final Results of the BRIGHT Phase III Clinical Trial Evaluating PRX-102 for the Treatment of Fabry Disease
Biopharmaceuticals
 HSMN NewsFeed - 15 Mar 2022
University Hospital Agostino Gemelli Treats its 1,000th Patient Using MRIdian(R) MRI-Guided Radiation Therapy
Devices Oncology
 HSMN NewsFeed - 11 Mar 2022
Terran Biosciences Announces Acquisition of a Portfolio of Novel CNS Therapeutics from Concert Pharmaceuticals
Biopharmaceuticals Neurology Acquisitions
 HSMN NewsFeed - 8 Mar 2022
CARTI Selects Accuray CyberKnife(R) S7(TM) System to Increase Access to Advanced Cancer Care for Patients in Rural Communities Throughout Arkansas
Devices Oncology
 HSMN NewsFeed - 8 Mar 2022
Electromedical Announces Addition of David Orn as Director of Business and Sales Development
Devices Personnel
 HSMN NewsFeed - 7 Mar 2022
Lyra Therapeutics Appoints Jim Tobin to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Mar 2022
Inhibrx Receives FDA Orphan-Drug Designation for INBRX-101 for the Treatment of Alpha-1 Antitrypsin Deficiency
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Mar 2022
RegeneRx Provides Regulatory Update Regarding RGN-259
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 1 Mar 2022
Zimmer Biomet Announces Completion of ZimVie Spinoff
Devices Orthopaedic Dental
 HSMN NewsFeed - 24 Feb 2022
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce the Submission of a Marketing Authorization Application to the European Medicines Agency for PRX-102 for the Treatment of Fabry Disease
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 17 Feb 2022
Prometheus Laboratories Announces the Launch of PredictrPK(TM) IFX, A Revolutionary Test Enabling Precision-Guided Dosing for Inflammatory Bowel Disease
Diagnostics Gastroenterology Product Launch
 HSMN NewsFeed - 11 Feb 2022
Nevro Announces Publication of 12-Month Data from SENZA-NSRBP Randomized Controlled Trial in Journal of Neurosurgery: Spine
Devices Neurosurgery
 HSMN NewsFeed - 10 Feb 2022
Ampio Expands Board of Directors with Addition of Elizabeth Varki Jobes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Feb 2022
Accuray TomoTherapy(R) Helical Radiotherapy System Helps Preserve Breast Cancer Patients' Long-term Heart and Lung Functionality
Devices Oncology
 HSMN NewsFeed - 7 Feb 2022
Zimmer Biomet Announces Expected Completion Date of March 1, 2022 for Spinoff of ZimVie
Devices Orthopaedic Dental Mergers & Acquisitions
 HSMN NewsFeed - 2 Feb 2022
Medtronic announces first procedure in Europe with Hugo(TM) robotic-assisted surgery system
Devices Surgery
 HSMN NewsFeed - 28 Jan 2022
FDA Accepts Label Update for Plasma IQ(TM), the First FDA-Cleared Handheld Plasma Energy Device
Devices Dermatology FDA
 HSMN NewsFeed - 28 Jan 2022
Blueprint Medicines' AYVAKYT(R) (avapritinib) Receives Positive CHMP Opinion for the Treatment of Adults with Advanced Systemic Mastocytosis
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 27 Jan 2022
FX Solutions, SAS. [FX Shoulder, Inc.] Completes Easytech Reversed(R) Stemless IDE Enrollment in the USA
Devices Orthopaedic
 HSMN NewsFeed - 24 Jan 2022
Lyra Therapeutics Announces Initiation of LYR-210 Pivotal Phase 3 ENLIGHTEN Program in Surgically Naïve Chronic Rhinosinusitis Patients
Devices Drug Delivery
 HSMN NewsFeed - 20 Jan 2022
BioTheryX Announces Appointment of Sahm Nasseri as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jan 2022
Vanda Pharmaceuticals Settles HETLIOZ(R) Patent Litigation with MSN
Biopharmaceuticals Generics Litigation Licensing
 HSMN NewsFeed - 12 Jan 2022
CBMG Receives FDA Regenerative Medicine Advanced Therapy and Fast Track Designations for Bi-Specific Anti-CD19/CD20 CAR-T Cell Therapy for Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Biopharmaceuticals Regenerative Medicine Oncology FDA
 HSMN NewsFeed - 3 Jan 2022
Zynex Submits FDA Application for its Next Generation Fluid and Blood Volume Monitor
Devices Monitoring FDA
 HSMN NewsFeed - 29 Dec 2021
MindMed Announces Transitions to Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Dec 2021
Petros Pharmaceuticals Announces Closing of $7.5 Million Offering
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Dec 2021
FDA Authorizes Further NurOwn(R) Dosing Under Expanded Access Program
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 23 Dec 2021
Zynex Announces Acquisition of Kestrel Labs
Devices Monitoring Mergers & Acquisitions
 HSMN NewsFeed - 20 Dec 2021
CytoSorbents Announces Publication of U.S. CTC Multicenter Registry Results Using CytoSorb(R) in Critically Ill COVID-19 Patients on Extracorporeal Membrane Oxygenation (ECMO)
Devices
 HSMN NewsFeed - 16 Dec 2021
Nordic Nanovector appoints Experienced International Life Sciences Executive Sandra Jonsson as Chief Operating Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 Dec 2021
ViewRay Receives 510(k) Clearance on Next Generation of MRIdian MRI-Guided Radiation Therapy Features
Devices Oncology FDA
 HSMN NewsFeed - 14 Dec 2021
MindMed Appoints Robert Barrow as Chief Executive Officer and Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Dec 2021
Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-422 for the Treatment of Advanced Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 6 Dec 2021
Sapience Therapeutics Receives FDA Fast Track Designation for ST101 for the Treatment of Recurrent Glioblastoma Multiforme (GBM)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 3 Dec 2021
Chemomab Therapeutics Names David M. Weiner, MD as Interim Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Nov 2021
Viracta Therapeutics Announces Orphan Drug Designation Granted by FDA for its All-Oral Combination of Nanatinostat and Valganciclovir (Nana-val) for the Treatment of Epstein Barr Virus-Positive Diffuse Large B-cell Lymphoma
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Nov 2021
HotSpot Therapeutics Closes $100M Series C to Advance First-in-Class Allosteric Drug Discovery Platform to the Clinic
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 24 Nov 2021
ViewRay Announces MRIdian MR-Guided Radiation Therapy Surpasses 2,300 Pancreatic Cancer Patients Treated Worldwide
Devices Oncology
 HSMN NewsFeed - 23 Nov 2021
Smith & Nephew Launches 'Turn-Key' Robotic-Assisted Surgical System; Designed to Quickly Augment the Orthopaedic Team's Skills Set for Greater Accuracy(1-3)¥, Improved Outcomes(4), and Potentially an Immediate Scalable Solution to NHS
Devices Orthopaedic Surgery Product Launch
 HSMN NewsFeed - 22 Nov 2021
Board Member Michael Martino to Become Interim Chairman and CEO of Ampio Pharmaceuticals, Mike Macaluso to Take Medical Leave
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Nov 2021
Rigel Sharpens Focus on Its Advanced Portfolio Opportunities
Biopharmaceuticals
 HSMN NewsFeed - 10 Nov 2021
Accuray CyberKnife(R) Robotic Radiotherapy Platform Expands Range of Neurological Indications That Can Be Effectively Treated With Stereotactic Radiosurgery
Devices Neurosurgery
 HSMN NewsFeed - 9 Nov 2021
Kintara Announces Changes to Executive Leadership Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Nov 2021
Chemomab Therapeutics Names Donald R. Marvin Chief Financial Officer, Executive Vice President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Nov 2021
BrainStorm Cell Therapeutics Expands Leadership Team to Support Clinical Development and Medical Affairs
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 4 Nov 2021
NeuroBo Pharmaceuticals Appoints Gil Price, M.D. as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Nov 2021
Trendlines Announces Acquisition of Portfolio Company OrthoSpin Ltd.
Devices Orthopaedic Mergers & Acquisitions
 HSMN NewsFeed - 1 Nov 2021
Theseus Pharmaceuticals Announces FDA Clearance of Investigational New Drug Application for THE-630, a Pan-Variant KIT Inhibitor in Development for the Treatment of Gastrointestinal Stromal Tumors (GIST)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 28 Oct 2021
Inhibrx Strengthens Leadership Team with Three Key Executive Hires and Announces Appointment of Kristiina Vuori, M.D., Ph.D. to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Oct 2021
NuVasive to Release Cutting-edge Virtual Reality Training for Lateral, Single-position Spine Surgery
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 25 Oct 2021
Helsinki University Hospital Selects MRIdian(R) System for Installation at Comprehensive Cancer Center
Devices Oncology
 HSMN NewsFeed - 20 Oct 2021
FDA Expands Approval of Dupixent(R) (dupilumab) to Include Children Aged 6 to 11 Years with Moderate-to-severe Asthma
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Oct 2021
vTv Therapeutics Announces Deepa Prasad as New President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Oct 2021
Accuray Unveils VOLO(TM) Ultra, the Latest Innovation for the Radixact(R) System, at ASTRO 2021
Devices Oncology
 HSMN NewsFeed - 18 Oct 2021
Oyster Point Pharma Announces FDA Approval of TYRVAYA(TM) (varenicline solution) Nasal Spray for the Treatment of the Signs and Symptoms of Dry Eye Disease
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 14 Oct 2021
NuVasive Launches Latest Porous PEEK Implant for Posterior Spine Surgery
Devices Neurosurgery Orthopaedic Product Launch
 HSMN NewsFeed - 14 Oct 2021
Immunic, Inc. Appoints Patrick Walsh as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Oct 2021
Poseida Therapeutics Announces Leadership Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Oct 2021
Medtronic Hugo(TM) Robotic-Assisted Surgery System Receives European CE Mark Approval
Devices Surgery Regulatory
 HSMN NewsFeed - 7 Oct 2021
Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel Precision Therapies for Brain Diseases
Biopharmaceuticals Neurology
 HSMN NewsFeed - 30 Sep 2021
Electromedical Technologies Receives Key Medical Device Certification
Devices Regulatory
 HSMN NewsFeed - 29 Sep 2021
French Hospital Network Unicancer Acquires Multiple Accuray Radixact(R) Systems with the ClearRT(TM) Helical Fan-Beam kVCT Imaging and Synchrony(R) Technologies
Devices Oncology
 HSMN NewsFeed - 27 Sep 2021
Synlogic Appoints Molly Harper as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Sep 2021
Japan's MHLW Approves PADCEV(R) (enfortumab vedotin) for Advanced Urothelial Cancer
Biopharmaceuticals Urology Oncology Regulatory
 HSMN NewsFeed - 27 Sep 2021
First Procedure in Asia-Pacific Performed with Medtronic Hugo(TM) Robotic-Assisted Surgery System
Devices Surgery
 HSMN NewsFeed - 22 Sep 2021
Kintara Reports Topline Results from Phase 2 Clinical Study of VAL-083 as Adjuvant Therapy for Newly-Diagnosed GBM Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Sep 2021
Sutro Biopharma Announces Expansion of Leadership Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 16 Sep 2021
LUMAKRAS(TM) (Sotorasib) Combined With Vectibix(R) (Panitumumab) Showed Encouraging Efficacy And Safety In Patients With KRAS G12C-Mutated Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Sep 2021
AbbVie and REGENXBIO Announce Eye Care Collaboration
Biopharmaceuticals Regenerative Medicine Ophthalmology
 HSMN NewsFeed - 10 Sep 2021
CytoSorbents Announces Filing of an Investigational Device Exemption (IDE) for the U.S. Clinical Trial on Apixaban and Rivaroxaban Removal by the DrugSorb-ATR(TM) Antithrombotic Removal System During Urgent Cardiothoracic Surgery
Devices Surgery FDA
 HSMN NewsFeed - 6 Sep 2021
U.S. FDA Placed a Clinical Hold on BMN 307 Phearless Phase 1/2 Gene Therapy Study in Adults with PKU Based on Interim Pre-clinical Study Findings
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Sep 2021
Chemomab Therapeutics Announces Appointment of Dale Pfost as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Aug 2021
Poseida Therapeutics Announces FDA Clearance of Investigational New Drug Application for P-BCMA-ALLO1, an Allogeneic CAR-T Candidate for Relapsed/Refractory Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 30 Aug 2021
Zimmer Biomet and Canary Medical Announce FDA De Novo Classification Grant and Authorization to Market the World's First and Only Smart Knee Implant
Devices Orthopaedic FDA
 HSMN NewsFeed - 13 Aug 2021
Memic Innovative Surgery Ltd. and MedTech Acquisition Corporation Announce Proposed Business Combination
Devices Surgery Mergers & Acquisitions
 HSMN NewsFeed - 13 Aug 2021
Rigel Pharmaceuticals Provides Update on COVID-19 Program
Biopharmaceuticals
 HSMN NewsFeed - 12 Aug 2021
Second U.S. FDA Breakthrough Device Designation Granted to CytoSorbents' DrugSorb-ATR(TM) Antithrombotic Removal System Adding the Removal of Market-Leading Direct Oral Anticoagulants During Urgent Cardiothoracic Surgery
Devices FDA
 HSMN NewsFeed - 11 Aug 2021
FDA Grants Lantern Pharma Orphan Drug Designation for Drug Candidate LP-184 in the Treatment of Pancreatic Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 9 Aug 2021
Sutro Biopharma Appoints Jane Chung as Chief Commercial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Aug 2021
Medtronic to Acquire Intersect ENT
Devices Mergers & Acquisitions
 HSMN NewsFeed - 2 Aug 2021
Abbott's FreeStyle(R) Libre 2 iOS App Cleared in U.S., Providing a Seamless Digital Experience to Simplify Diabetes Management
Devices Monitoring Endocrinology FDA
 HSMN NewsFeed - 30 Jul 2021
NuVasive Receives Latest FDA 510(k) Clearance for Pulse Platform and Announces Commercial Launch
Devices Neurosurgery Orthopaedic FDA Product Launch
 HSMN NewsFeed - 29 Jul 2021
Oramed Pharmaceuticals Appoints Chief Commercial Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 28 Jul 2021
Ring Therapeutics Raises $117 Million in Series B Funding to Expand Novel Vector Platform to Unlock the Full Potential of Gene Therapy
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Jul 2021
Hong Kong Sanatorium & Hospital Transforms Cancer Care in Asia with Treatment of First Patient Using the Accuray Radixact(R) System and ClearRT(TM) Helical Fan-Beam kVCT Imaging
Devices Oncology
 HSMN NewsFeed - 22 Jul 2021
NuVasive Launches Modulus ALIF 3D-Printed Porous Titanium Implant for Anterior Spine Surgery
Devices Neurosurgery Orthopaedic Product Launch
 HSMN NewsFeed - 19 Jul 2021
Nektar Appoints Dimitry S.A. Nuyten, M.D., Ph.D., as Senior Vice President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jul 2021
Nevro Announces FDA Approval of its 10 kHz High Frequency Spinal Cord Stimulation Therapy for Treatment of Chronic Pain Associated with Painful Diabetic Neuropathy (PDN)
Devices Neurology FDA Product Launch
 HSMN NewsFeed - 6 Jul 2021
Viracta Therapeutics Announces the Appointment of Ayman El-Guindy, Ph.D., as Chief Scientific Officer and Key Additions to Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jun 2021
CardioFocus Appoints Stephan Ogilvie as Chief Financial Officer
Devices Cardiology Personnel
 HSMN NewsFeed - 28 Jun 2021
Palatin Announces New Additions to Its Senior Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jun 2021
Jazz Pharmaceuticals Announces Orphan Drug Exclusivity for Xywav(TM) (calcium, magnesium, potassium, and sodium oxybates) Oral Solution
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Jun 2021
Evrysdi(TM) Approved in Japan for the Treatment of Spinal Muscular Atrophy
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 Jun 2021
First Procedure in the World with Medtronic Hugo(TM) Robotic-Assisted Surgery System Performed at Clínica Santa Maria in Chile
Devices Surgery
 HSMN NewsFeed - 22 Jun 2021
ViiV Healthcare and Halozyme enter global collaboration and license agreement for ENHANZE(R) drug delivery technology to enable development of "ultra-long-acting" medicines for HIV
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 16 Jun 2021
Accuray Expands CyberKnife(R) System Versatility with Integration of RaySearch's RayStation Treatment Planning System
Devices Oncology Product Launch
 HSMN NewsFeed - 14 Jun 2021
FDA Clears LPCN 1154 IND Application for a Phase 2 Postpartum Depression Study
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 Jun 2021
MindMed Announces Chief Executive Officer Transition
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jun 2021
CardioFocus Announces Agreement with China Grand Pharmaceutical to Bring HeartLight X3 System to China
Devices Interventional Cardiology Licensing
 HSMN NewsFeed - 1 Jun 2021
Amgen and Kyowa Kirin to Jointly Develop and Commercialize KHK4083, a Phase 3-Ready, Potential First-In-Class Treatment for Atopic Dermatitis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 19 May 2021
LogicBio Therapeutics Promotes Daniel Gruskin, MD, to Chief Medical Officer and Announces Additional Leadership Appointments
Biopharmaceutical Personnel
 HSMN NewsFeed - 13 May 2021
MindMed Bolsters Management Team, Appoints Peter Mack PhD as Vice President of Pharmaceutical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 May 2021
Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 4 May 2021
Beckman Coulter is First Diagnostics Company to Offer Workflow Automation Specifically for Mid-volume Laboratories
Diagnostics Product Launch
 HSMN NewsFeed - 4 May 2021
Astellas' XTANDI(TM) (enzalutamide) Approved by European Commission for Men with Metastatic Hormone-Sensitive Prostate Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 30 Apr 2021
Blue Therapeutics announces Series A raise
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Apr 2021
Caresyntax Raises $100 Million to Make Surgery Smarter and Safer
Devices Surgery Venture Capital
 HSMN NewsFeed - 28 Apr 2021
Protalix BioTherapeutics and Chiesi Global Rare Diseases Receive Complete Response Letter for Pegunigalsidase Alfa from FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Apr 2021
NeuroOne Appoints Medtronic Veteran, Hijaz Haris, as Vice President of Marketing
Devices Neurology Personnel
 HSMN NewsFeed - 26 Apr 2021
Accuray Appoints Jean-Philippe Pignol, M.D., Ph.D. as Chief Medical & Technology Officer
Devices Oncology Personnel
 HSMN NewsFeed - 22 Apr 2021
Accuray Receives Shonin Approval for ClearRT(TM) Helical kVCT Imaging, CE Mark Expected by End of June; Expands Commercial Launch
Devices Oncology Regulatory
 HSMN NewsFeed - 21 Apr 2021
Johnson & Johnson Vision Receives FDA Clearance and CE Mark for Next-Generation Phacoemulsification Machine, VERITAS(TM) Vision System
Devices Ophthalmology FDA Regulatory
 HSMN NewsFeed - 19 Apr 2021
Amgen Launches Biomarker Assist(TM), a Program To Help More Patients With Non-Small Cell Lung Cancer Gain Access To Biomarker Testing
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 19 Apr 2021
Haemonetics Provides Update On U.S. Plasma Business
Devices
 HSMN NewsFeed - 16 Apr 2021
Amgen Successfully Completes Acquisition Of Five Prime Therapeutics
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 15 Apr 2021
Vicarious Surgical Inc. and D8 Holdings Corp. Announce Definitive Business Combination Agreement
Devices Surgery Mergers & Acquisitions
 HSMN NewsFeed - 14 Apr 2021
OncoSec Receives CE Mark Certification for its Commercial Electroporation Device "GenPulse(TM)" for the Treatment of Solid Tumors
Devices Oncology Regulatory
 HSMN NewsFeed - 14 Apr 2021
HotSpot Therapeutics Appoints Timothy Reilly as Chief Development Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Apr 2021
Abbott Receives CE Mark Approval for Next-Generation TriClip(TM) Device, Offering New Innovations for Tricuspid Heart Valve Repair
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 6 Apr 2021
Seelos Therapeutics Announces a Strategic Device Partnership with AptarGroup, Inc.
Biopharmaceuticals Devices Drug Delivery
 HSMN NewsFeed - 1 Apr 2021
United Therapeutics Announces FDA Approval and Launch of Tyvaso(R) for the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
Biopharmaceuticals FDA Product Launch
 HSMN NewsFeed - 31 Mar 2021
CTI BioPharma Announces Completion of Rolling Submission of New Drug Application (NDA) for Pacritinib in Myelofibrosis Patients with Severe Thrombocytopenia
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Mar 2021
PTC Therapeutics Announces the European Approval of Evrysdi(TM) for the Treatment of Spinal Muscular Atrophy
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 26 Mar 2021
European Medicines Agency Accepts Marketing Authorization Application for Enfortumab Vedotin
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 23 Mar 2021
Poseida Therapeutics Announces Carl June, M.D., to Chair Immuno-Oncology Scientific Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Mar 2021
Oakrum Pharma and Aucta Pharma Announce U.S. FDA Approval of Generic Version of JADENU(R) Sprinkle (Deferasirox Granules)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 22 Mar 2021
Sutro Biopharma Strengthens Leadership Through Management Promotions and Expansion of Clinical Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Mar 2021
Oramed Forms a Joint Venture, Oravax Medical Inc., for the Development of Novel Oral COVID-19 Vaccines
Biopharmaceuticals
 HSMN NewsFeed - 16 Mar 2021
Merck KGaA, Darmstadt, Germany, Reports Topline Data for Bintrafusp Alfa as Second-Line Monotherapy Treatment in Biliary Tract Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Mar 2021
ViewRay Announces Departure of Chief Operating Officer
Devices Personnel
 HSMN NewsFeed - 2 Mar 2021
Varian Announces CEO Succession Plan
Devices Oncology Personnel Mergers & Acquisitions
 HSMN NewsFeed - 23 Feb 2021
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Positive Topline Results from BRIGHT Phase III Open-Label, Switch-Over Clinical Trial Evaluating Pegunigalsidase Alfa 2 mg/kg every Four Weeks for Treatment of Fabry Disease
Biopharmaceuticals
 HSMN NewsFeed - 19 Feb 2021
Astellas Announces Positive Topline Results from Two Phase 3 Pivotal Global Trials of Fezolinetant for the Nonhormonal Treatment of Vasomotor Symptoms in Postmenopausal Women
Biopharmaceuticals
 HSMN NewsFeed - 18 Feb 2021
OncoSec Appoints Bridget O'Keeffe, Ph.D. as Vice President of Clinical Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 18 Feb 2021
Lilly and Rigel Enter Strategic Collaboration to Develop RIPK1 Inhibitors for the Potential Treatment of Immunological and Neurodegenerative Diseases
Biopharmaceuticals Licensing
 HSMN NewsFeed - 12 Feb 2021
The Lancet Publishes Libtayo(R) (cemiplimab) Data Showing Extended Overall Survival in Patients with First-line Advanced Non-small Cell Lung Cancer with PD-L1 Expression of ≥50%
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Feb 2021
Protalix BioTherapeutics Enters into an Exclusive Partnership with SarcoMed USA to Develop alidornase alfa for the Treatment of Pulmonary Sarcoidosis and Related Respiratory Diseases Via Inhaled Delivery
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 11 Feb 2021
Penn State Health Purchases Second ViewRay MRIdian(R) Linac
Devices Radiology Oncology
 HSMN NewsFeed - 5 Feb 2021
Zimmer Biomet Announces Intent to Spin Off Spine and Dental Businesses
Devices Orthopaedic Neurosurgery Dental
 HSMN NewsFeed - 2 Feb 2021
OncoSec Strengthens Management Team With Two New Appointments
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 26 Jan 2021
The Henry Ford Cancer Institute Installs its Second ViewRay MRIdian(R) Linac
Devices Oncology
 HSMN NewsFeed - 25 Jan 2021
OrthoSpin Ltd. Receives FDA Regulatory Clearance for its G2 System
Devices Orthopaedic FDA
 HSMN NewsFeed - 25 Jan 2021
Eiger BioPharmaceuticals Announces U.S. Commercial Availability of Zokinvy(TM) (lonafarnib), the First and Only Treatment Approved for Progeria and Processing-Deficient Progeroid Laminopathies
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 20 Jan 2021
Haemonetics To Acquire Cardiva Medical, Inc. To Expand Hospital Portfolio
Devices Mergers & Acquisitions
 HSMN NewsFeed - 19 Jan 2021
Lilly and Merus NV Announce Collaboration to Discover Novel T-Cell Re-Directing Bispecific Antibodies
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Jan 2021
NeuroOne Medical Technologies Corporation Closes $12.5 Million Private Placement with Certain Prominent Institutional Investors, Advances Towards Nasdaq Uplisting
Devices Neurology Venture Capital
 HSMN NewsFeed - 15 Jan 2021
Lilly Announces $30 Million Limited Partner Investment in Unseen Capital Health Fund
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Jan 2021
Delfi Diagnostics Announces $100 Million Series A Financing to Develop a New Class of Early Detection Liquid Biopsy for Multiple Cancers
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 11 Jan 2021
CytoSorbents Appoints James Komsa as Vice President - U.S. Sales and Marketing
Devices Personnel
 HSMN NewsFeed - 7 Jan 2021
Kira Pharmaceuticals Announces $53.5 Million Series B+ Financing to Advance LOGIC Drug Discovery Platform and Pipeline of Complement-targeted Therapies
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Jan 2021
Enveric Biosciences Appoints Dr. Marcus Schabacker to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jan 2021
Endo Launches Authorized Generic Version of Amitiza(R) (lubiprostone) Capsules in the United States
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 30 Dec 2020
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Final Results of BRIDGE Phase III Open-Label, Switch-Over Clinical Trial Evaluating Pegunigalsidase Alfa for the Treatment of Fabry Disease
Biopharmaceuticals
 HSMN NewsFeed - 29 Dec 2020
AIVITA Biomedical Closes $25 Million Financing Round
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 22 Dec 2020
Soligenix Announces Topline Results from its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Dec 2020
Update On SOURCE Phase 3 Trial For Tezepelumab In Patients With Severe, Oral Corticosteroid-Dependent Asthma
Biopharmaceuticals
 HSMN NewsFeed - 21 Dec 2020
Anixa Biosciences and Cleveland Clinic Announce FDA Clearance to Initiate Clinical Trial of Breast Cancer Vaccine
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 21 Dec 2020
Onkos Surgical(R) continues its innovation in musculoskeletal oncology and complex orthopaedic reconstruction with the launch of the ELEOS(TM) Proximal Tibia with BioGrip(TM) technology
Devices Oncology Orthopaedic Product Launch
 HSMN NewsFeed - 21 Dec 2020
Astellas Reports XOSPATA(R) (gilteritinib) in Combination with Azacitidine Did Not Meet Endpoint of Overall Survival in Newly Diagnosed FLT3 Mutation-Positive Acute Myeloid Leukemia Patients Ineligible for Intensive Induction Chemotherapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Dec 2020
Nuvo Pharmaceuticals(R) Announces Corporate Rebranding as Miravo Healthcare(TM)
Biopharmaceuticals
 HSMN NewsFeed - 17 Dec 2020
Leading BioSciences and Seneca Biopharma Announce Merger
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Dec 2020
Almirall announces FDA approval of Klisyri(R) (tirbanibulin), a new innovative topical treatment for actinic keratosis
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 15 Dec 2020
MinervaX raises upsized EUR 47.4M (USD 57M) Series B to advance its novel Group B Streptococcus vaccine through mid-stage clinical trials
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 14 Dec 2020
Efemoral Medical Announces Successful First-In-Human Use of the Efemoral(TM) Vascular Scaffold System
Devices Interventional
 HSMN NewsFeed - 8 Dec 2020
Amgen's Sotorasib Granted Breakthrough Therapy Designation for Advanced or Metastatic Non-Small Cell Lung Cancer Patients with KRAS G12C Mutation
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 7 Dec 2020
KaliVir Immunotherapeutics and Astellas Enter Worldwide Exclusive Licensing Agreement for Development and Commercialization of VET2-L2 Novel Oncolytic Virus
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 4 Dec 2020
PTC Announces Translarna(TM) Approval in Russia for the Treatment of Duchenne Muscular Dystrophy
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 3 Dec 2020
NeuroOne(R) Medical Technologies Corporation Announces First Human Commercial Use of its Evo(TM) Cortical Electrode at Mayo Clinic
Devices Neurosurgery
 HSMN NewsFeed - 2 Dec 2020
Obiltoxaximab Receives Marketing Authorization From European Commission For The Treatment Of Inhalation Anthrax
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 30 Nov 2020
PTC Therapeutics Announces Initiation of Global Phase 3 Clinical Trial to Evaluate Vatiquinone in Friedreich Ataxia
Biopharmaceuticals
 HSMN NewsFeed - 30 Nov 2020
Cogent Biosciences Appoints Brad Barnett as Chief Technology Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Nov 2020
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Extension of PDUFA Date for Pegunigalsidase Alfa for the Proposed Treatment of Fabry Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Nov 2020
Eiger BioPharmaceuticals Announces FDA Approval of Zokinvy(TM) (lonafarnib): The First Treatment for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Nov 2020
Rigel and Medison Announce Health Canada Approval of TAVALISSE(R), an Oral Medication for the Treatment of Adults with Chronic Immune Thrombocytopenia
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 Nov 2020
BrainStorm to present NurOwn(R) Phase 3 Clinical Trial Results at 31st International Symposium on ALS/MND
Regenerative Medicine Neurology
 HSMN NewsFeed - 18 Nov 2020
NuVasive Expands Proprietary Porous PEEK Portfolio with Cohere XLIF Interbody
Devices Neurosurgery Orthopaedic Product Launch
 HSMN NewsFeed - 18 Nov 2020
Sutro Biopharma Announces the Appointment of Diana Landa as Vice President of Regulatory Affairs and Annie Chang as Head of Investor Relations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 17 Nov 2020
BrainStorm Announces Topline Results from NurOwn(R) Phase 3 ALS Study
Regenerative Medicine Neurology
 HSMN NewsFeed - 17 Nov 2020
SafKan Health Announces FDA 510(k) Clearance for First-of-its-Kind OtoSet(TM) Ear Cleaning System
Devices FDA
 HSMN NewsFeed - 12 Nov 2020
Kira Pharmaceuticals Launches to Pioneer Novel Therapeutics for Complement-Mediated Diseases
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 10 Nov 2020
Penumbra Announces Partnership with RapidAI to Enable Faster Clinical Decision-Making for Pulmonary Embolism
Devices
 HSMN NewsFeed - 10 Nov 2020
Tezepelumab NAVIGATOR Phase 3 Trial Met Primary Endpoint Of A Statistically Significant And Clinically Meaningful Reduction In Exacerbations In A Broad Population Of Patients With Severe Asthma
Biopharmaceuticals
 HSMN NewsFeed - 6 Nov 2020
BioElectronics' ActiPatch(R) Therapy To Be Marketed By DonJoy(R) Advantage
Devices Orthopaedic Distribution
 HSMN NewsFeed - 6 Nov 2020
XTANDI(R) (enzalutamide soft capsules) Approved by China NMPA for the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 2 Nov 2020
Boston Scientific Receives FDA Approval for the Ranger(TM) Drug-Coated Balloon
Devices Interventional FDA Product Launch
 HSMN NewsFeed - 28 Oct 2020
Accuray Announces Agreement with Brainlab to Expand CyberKnife(R) Platform Treatment Capabilities for the Neuro-Radiosurgery Market
Devices Neurosurgery Oncology
 HSMN NewsFeed - 26 Oct 2020
Armata Pharmaceuticals Appoints Mina Pastagia, MD, MS as Vice President of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Oct 2020
Jazz Pharmaceuticals Acquires SpringWorks Therapeutics' FAAH Inhibitor Program
Biopharmaceuticals Licensing Acquisitions
 HSMN NewsFeed - 26 Oct 2020
Cogent Biosciences Appoints Andrew Robbins as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Oct 2020
Accuray Appoints Mike Leischer Vice President and General Manager, Americas Region
Devices Oncology Personnel
 HSMN NewsFeed - 19 Oct 2020
BioSpecifics to be Acquired by Endo Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 16 Oct 2020
Akero Therapeutics Receives European Medicines Agency Priority Medicines (PRIME) Designation for Efruxifermin (EFX) in NASH
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Oct 2020
Titan Pharmaceuticals Provides a Strategic & Corporate Update
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Oct 2020
Harmony Biosciences Receives FDA Approval For Expanded Use Of WAKIX(R) (pitolisant) For The Treatment Of Cataplexy In Adult Patients With Narcolepsy
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Oct 2020
Louis Stokes Cleveland VA Medical Center Purchases ViewRay's MRIdian Linac for MRI-Guided Radiation Therapy
Devices Oncology
 HSMN NewsFeed - 12 Oct 2020
OncoSec Announces Appointment of Sandra Aung, Ph.D. as Senior Vice President, Chief Clinical Development Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 Oct 2020
Exact Sciences and Pfizer Extend and Amend Cologuard(R) Promotion Agreement
Diagnostics Oncology
 HSMN NewsFeed - 6 Oct 2020
Halozyme Announces Expansion Of Collaboration And License Agreement With argenx For ENHANZE(R) Technology
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 30 Sep 2020
Achieve Life Sciences Announces Appointment of John Bencich to Chief Executive Officer & Dr. Cindy Jacobs to President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Sep 2020
Medtronic to Acquire Avenu Medical
Devices Mergers & Acquisitions
 HSMN NewsFeed - 25 Sep 2020
Blueprint Medicines Announces European Commission Approval of AYVAKYT(R) (avapritinib) for the Treatment of Adults with Unresectable or Metastatic PDGFRA D842V Mutant Gastrointestinal Stromal Tumors
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 17 Sep 2020
Accuray Radixact(R) System with Synchrony(R) Technology Delivers Advanced Cancer Treatments at Multiple Hospitals in Japan
Devices Oncology
 HSMN NewsFeed - 14 Sep 2020
Varian Announces Appointment of Chris Toth as President and Chief Operating Officer
Devices Oncology Personnel
 HSMN NewsFeed - 14 Sep 2020
CollPlant Biotechnologies Signs Distribution Agreement for its Vergenix Flowable Gel Product in the Commonwealth of Independent States (CIS)
Devices Regenerative Medicine Wound Care Distribution
 HSMN NewsFeed - 8 Sep 2020
Menlo Therapeutics Announces Completion of Corporate Name Change to VYNE Therapeutics
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 8 Sep 2020
Mylan to Acquire Aspen's Thrombosis Business in Europe
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 4 Sep 2020
I-Mab Announces $418 Million Private Placement with Hillhouse Capital-Led Consortium
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Sep 2020
10,000th Patient Receives Treatment with ViewRay's MRIdian System
Devices Radiology Oncology
 HSMN NewsFeed - 24 Aug 2020
Yumanity Therapeutics and Proteostasis Therapeutics Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Aug 2020
Cipla and Stempeutics collaborate for launch of Stempeucel(R), first 'Made in India' Cell Therapy to treat Critical Limb Ischemia (CLI)
Biopharmaceuticals Regenerative Medicine
 HSMN NewsFeed - 13 Aug 2020
Thermo Fisher Scientific Announces Results of Offer to Acquire QIAGEN, Lapse of Offer and Termination of Acquisition Agreement
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 13 Aug 2020
Dartmouth-Hitchcock Health Begins Patient Treatments with ViewRay's MRIdian Linac
Devices Radiology Oncology
 HSMN NewsFeed - 7 Aug 2020
Lodo Therapeutics Acquires Conifer Point Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 7 Aug 2020
Haemonetics Clinical Study Results On A New, Personalized Approach To Plasma Collection To Be Presented At 2020 AABB Annual Meeting
Devices
 HSMN NewsFeed - 2 Aug 2020
Varian to Combine with Siemens Healthineers in $16.4 Billion All-Cash Transaction
Devices Oncology Mergers & Acquisitions
 HSMN NewsFeed - 31 Jul 2020
CytoSorbents Awarded $4.4 Million Contract by the U.S. Department of Defense to Complete HemoDefend-BGA Adsorber Preclinical Development
Devices
 HSMN NewsFeed - 29 Jul 2020
Jay Pharma to File IND Applications to FDA for a clinical study of proprietary formulations in Radiodermatitis and a combination Therapy in Glioblastoma
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Jul 2020
UCB enters into collaboration with Roche to develop antibody treatment for people living with Alzheimer's Disease
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 28 Jul 2020
CytoSorbents Announces the REFRESH 2-AKI Trial Data Monitoring Committee Has Recommended Study Resumption Following Favorable Review of Safety Data
Devices
 HSMN NewsFeed - 27 Jul 2020
CARISMA Therapeutics Announces FDA Clearance of IND Application for First-Ever Engineered Macrophage Immunotherapy
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 Jul 2020
Insmed Receives Positive CHMP Opinion for ARIKAYCE Liposomal 590 mg Nebuliser Dispersion for the Treatment of NTM Lung Infections Caused by MAC in Non-CF Patients with Limited Treatment Options
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 24 Jul 2020
Bimekizumab Superior to Cosentyx(R) in Achieving Complete Psoriasis Skin Clearance
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 22 Jul 2020
Cerapedics Announces FDA approval of an IDE supplement
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 22 Jul 2020
Jazz Pharmaceuticals Announces U.S. FDA Approval of Xywav(TM) (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Cataplexy or Excessive Daytime Sleepiness Associated with Narcolepsy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 16 Jul 2020
Imvax Inc. Raises $112 Million in Series C Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 15 Jul 2020
Edwards' KONECT RESILIA Aortic Valved Conduit Receives FDA Approval For Complex Aortic Valve Surgeries
Devices Cardiology Surgery FDA
 HSMN NewsFeed - 6 Jul 2020
ANI Pharmaceuticals Announces Acquisition of Fluconazole Tablets
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 30 Jun 2020
ANI Pharmaceuticals Announces Launch of Mexiletine Hydrochloride Capsules
Biopharmaceuticals Cardiology Generics Product Launch
 HSMN NewsFeed - 24 Jun 2020
CytoSorbents Announces Commercial Launch and Immediate Availability of CytoSorb To Treat Cytokine Storm In Many Latin American Countries As COVID-19 Cases Rise
Devices Product Launch
 HSMN NewsFeed - 24 Jun 2020
BrainStorm Expands Clinical Pipeline to Evaluate NurOwn(R) for the Treatment of Alzheimer's Disease
Regenerative Medicine Neurology
 HSMN NewsFeed - 23 Jun 2020
Polynoma Receives FDA Fast Track Designation for its Melanoma Cancer Vaccine Seviprotimut-L
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 22 Jun 2020
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
Diagnostics Oncology Mergers & Acquisitions
 HSMN NewsFeed - 19 Jun 2020
Dupixent(R) (dupilumab) Approved in China for Adults with Moderate-to-Severe Atopic Dermatitis
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 18 Jun 2020
Almirall Announces FDA Approval Of Updated Label For Seysara(R) (Sarecycline) Tablets
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 18 Jun 2020
NuVasive Expands Complex Spine Portfolio with Global Launch of Reline 3D for Pediatric Deformity
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 17 Jun 2020
Accuray Launches New CyberKnife(R) S7(TM) System
Devices Oncology Product Launch
 HSMN NewsFeed - 11 Jun 2020
Sciton Unveils Newest Aesthetic Platform, mJOULE(TM) Featuring BBL HERO(TM) And MOXI(TM)
Devices Dermatology Product Launch
 HSMN NewsFeed - 10 Jun 2020
Akero Therapeutics Appoints Tom Heyman to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jun 2020
Insmed Receives FDA Breakthrough Therapy Designation for Brensocatib in Patients with Non-Cystic Fibrosis Bronchiectasis (NCFBE)
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Jun 2020
UCB Acquires Engage Therapeutics: Staccato(R) Alprazolam - A potential Solution for Acute On-demand Seizure Management for People Living With Epilepsy
Devices Drug Delivery Neurology Mergers & Acquisitions
 HSMN NewsFeed - 1 Jun 2020
PTC Therapeutics Successfully Completes Acquisition of Censa Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 1 Jun 2020
Lilly Begins World's First Study of a Potential COVID-19 Antibody Treatment in Humans
Biopharmaceuticals
 HSMN NewsFeed - 29 May 2020
XTANDI(R) (enzalutamide) Approved by Japan MHLW for the Treatment of Prostate Cancer with Distant Metastasis
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 28 May 2020
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Submission of Biologics License Application to U.S. Food and Drug Administration for Pegunigalsidase Alfa for the Treatment of Fabry Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 May 2020
BrainStorm Appoints Pharmaceutical Veteran Stacy R. Lindborg, Ph.D. as Executive Vice President, Head of Global Clinical Research
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 27 May 2020
Bausch & Lomb Announces The European Launch Of LuxSmart(TM) And LuxGood(TM) Preloaded Intraocular Lenses
Devices Ophthalmology Product Launch
Return to NewsFeed  

 Additional items found! 500

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 500 additional stories matching:
Toric
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!